Zynerba Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Zynerba Pharmaceuticals Ownership

Who owns Zynerba Pharmaceuticals?

Zynerba Pharmaceuticals is owned by Harmony Biosciences. It was acquired on August 14, 2023.

Zynerba Pharmaceuticals Business Overview

Where is Zynerba Pharmaceuticals headquartered?

Zynerba Pharmaceuticals is headquartered in Devon, Pennsylvania.

How many employees does Zynerba Pharmaceuticals have?

Zynerba Pharmaceuticals has 25 employees.

What sector is Zynerba Pharmaceuticals in?

Zynerba Pharmaceuticals is a life science company.

When was Zynerba Pharmaceuticals founded?

Zynerba Pharmaceuticals was founded in 2007.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 206 acquisitions of life science companies in 2023, including 27 acquisitions by private equity firms, and 179 by strategics.

Zynerba Pharmaceuticals

Zynerba Pharmaceuticals, Inc.

80 West Lancaster Avenue Suite 300,
Devon, Pennsylvania 19333
United States,
(484) 581-7505
www.zynerba.com

Zynerba Pharmaceuticals is a pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, including Fragile X syndrome (FXS). Zynerba Pharmaceuticals was founded in 2007 and is based in Devon, Pennsylvania.


 Subscribe to unlock this and 209,235
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.